This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Carter's (CRI) Q2 Earnings Beat, Retail Comps Down 11.7%
by Zacks Equity Research
Carter's (CRI) posts soft sales results in second-quarter 2024, owing to weak sales across the U.S. Retail and International segments.
Carter's (CRI) Q2 Earnings Beat Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 68.89% and 0.42%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter's (CRI) Q2 Earnings Coming Up: What's in the Cards?
by Zacks Equity Research
Carter's (CRI) second-quarter 2024 results are likely to reflect slow online sales, inflationary impacts and increased store payroll expenses.
Zacks Industry Outlook Highlights Adidas, Skechers, Caleres and Wolverine World Wide
by Zacks Equity Research
Adidas, Skechers, Caleres and Wolverine World Wide are part of the Zacks Industry Outlook article.
Carter's (CRI) Stock Dips 23% in 3 Months: What You Should Know
by Zacks Equity Research
Carter's (CRI) is battling with various uncertainties such as troubles in the business environment, inflation, generational high interest rates, higher consumer debt levels and recession risks.
Nike (NKE) Beats Q4 Earnings Estimates
by Zacks Equity Research
Nike (NKE) delivered earnings and revenue surprises of 18.82% and 2.13%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter's (CRI) Gains From Robust Strategies Amid Inflation Woes
by Zacks Equity Research
Carter's (CRI) pricing strategy, efficient inventory management and enhanced product offerings have been driving growth amid the ongoing unfavorable impact of inflation.
Carter's (CRI) Q1 Earnings Improve Y/Y, Sales Decline 4.9%
by Zacks Equity Research
Carter's (CRI) experiences higher and earlier-than-expected demand from its largest wholesale customers in Q1.
Carter's (CRI) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Here's How Carter's (CRI) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
Carter's (CRI) first-quarter 2024 results are likely to reflect inflationary impacts and increased performance-based compensation provisions.
Here's Why Carter's (CRI) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Why Carter's (CRI) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Carter's (CRI) Up 1.5% Since Last Earnings Report?
by Zacks Equity Research
Carter's (CRI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Carter's (CRI) Stock Looks Well Poised for Growth
by Zacks Equity Research
Carter's (CRI) strategic efforts are on track. The company is gaining from pricing strategy, inventory management efforts and improved product offerings.
Why Carter's (CRI) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Why Carter's (CRI) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Carter's (CRI) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Carter's (CRI) Strategic Efforts Bode Well: Apt to Hold
by Zacks Equity Research
Carter's (CRI) strategic efforts are on track. The company is gaining from pricing strategy, inventory management efforts and improved product offerings.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Carter's (CRI) Q4 Earnings Surpass Estimates, Sales Decline Y/Y
by Zacks Equity Research
Carter's (CRI) posts mixed fourth-quarter 2023 results, wherein the bottom line beat the Zacks Consensus Estimate while the top line missed.
Carter's (CRI) Tops Q4 Earnings Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 9.52% and 0.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Carter's (CRI) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Carter's (CRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.